Valhalla, NYNCT02393157Now EnrollingIRB Ready

Non-Hodgkin Lymphoma Clinical Trial in Valhalla, NY

Access cutting-edge non-hodgkin lymphoma treatment through this clinical trial at a research site in Valhalla. Study-provided care at no cost to qualified participants.

Sponsored by New York Medical College

Quick Self-Assessment

See if you qualify for this Valhalla location

Preparing your pre-screening questions…

Expert Care in Valhalla

Access non-hodgkin lymphoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-hodgkin lymphoma treatment provided free

Apply for This Valhalla Location

Check if you qualify for this non-hodgkin lymphoma clinical trial in Valhalla, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Valhalla

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Valhalla site if eligible
  4. 4Begin participation

About This Non-Hodgkin Lymphoma Study in Valhalla

The purpose of this study is to determine the safety of administering obinutuzumab as a single agent alone and in combination with ifosfamide, carboplatin, and etoposide (ICE) chemotherapy and determine the response rate of this treatment for children, adolescents and young adults (CAYA) with relapsed CD20 positive B-cell Non-Hodgkin Lymphoma (B-NHL).

Sponsor: New York Medical College

Who Can Participate

Inclusion Criteria

Patients in first relapse or primary induction failure CD20 positive B-cell leukemia/lymphoma including:
Diffuse Large B-Cell Lymphoma
Burkitt Lymphoma
High Grade B-cell Lymphoma: Not Otherwise Specified (NOS)
Primary mediastinal B-cell lymphoma (PMBL)
CD20+ B-lymphoblastic lymphoma
Follicular lymphoma, Grade III
Karnofsky ≥ 60% for patients \> 16 years of age and
Lansky ≥ 60 for patients ≤ 16 years of age.
Myelosuppressive chemotherapy: Must not have received within 2 weeks of entry onto this study.
Patients may not have received prior therapy with obinutuzumab (GA101)
Radiation Therapy (XRT): Date of receiving prior XRT must be \> 2 weeks for local palliative XRT (small port); \> 6 months must have elapsed if prior craniospinal XRT or if \> 50% radiation of pelvis; \> 6 weeks must have elapsed if other substantial bone marrow radiation.
Steroids: Patients may have received prior steroid treatment, but not started greater than 7 days prior to initiation of protocol therapy.
Adequate organ function.

Exclusion Criteria

Patients with newly diagnosed, previously untreated B-NHL.
Known congenital or acquired immune deficiency.
Prior solid organ transplantation.
Prior allogeneic stem cell transplant within 60 days or active acute Graft-vs-Host-Disease (GVHD) grade 3 or higher.
History of grade 4 anaphylactic reactions to humanized or murine monoclonal antibodies
Uncontrolled hepatitis B and/or C infection

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Valhalla?

Yes, this clinical trial (NCT02393157) has an active research site in Valhalla, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-Hodgkin Lymphoma Treatment Options in Valhalla, NY

If you're searching for non-hodgkin lymphoma treatment options in Valhalla, NY, this clinical trial (NCT02393157) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Valhalla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-hodgkin lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-hodgkin lymphoma clinical trials near you to find additional studies recruiting in your area.

More Lymphoma Trials in Valhalla, NY

See all lymphoma clinical trials recruiting in Valhalla — not just this study.

Browse Lymphoma Trials in Valhalla →

Browse More Trials by Condition

Lymphoma TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Valhalla?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Valhalla, NY